AI Tokens
Stock Analysis on Net

Analysis of Long-term (Investment) Activity Ratios
Quarterly Data

Microsoft Excel

Long-term Activity Ratios (Summary)

UnitedHealth Group Inc., long-term (investment) activity ratios (quarterly data)

Microsoft Excel
Sep 30, 2026 Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Net fixed asset turnover 40.69 41.44 41.78 41.22 38.75 38.22 37.72 37.44 38.37 38.90 35.98 32.10 32.18 31.60 31.35 31.81 33.07 32.33 32.16
Total asset turnover 1.42 1.44 1.43 1.43 1.36 1.35 1.31 1.32 1.30 1.33 1.32 1.34 1.26 1.23 1.18 1.31 1.29 1.32 1.33
Equity turnover 4.54 4.53 4.55 4.71 4.49 4.41 4.26 4.26 4.12 4.27 4.33 4.14 4.22 4.19 4.10 4.14 4.19 4.18 4.06

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The analysis of investment activity ratios reveals a general improvement in asset utilization efficiency over the observed period, with a notable acceleration in productivity starting in early 2024. While total asset efficiency remained relatively stable, there were significant gains in the productivity of fixed assets and equity.

Net Fixed Asset Turnover
A pronounced upward trend is observed in the net fixed asset turnover ratio. From March 2022 through December 2023, the ratio remained largely range-bound between 31.35 and 33.07. However, a structural shift occurred in March 2024, where the ratio climbed to 35.98 and continued a steady ascent, peaking at 41.78 by March 2026. This indicates a substantial increase in the company's ability to generate revenue from its fixed asset investments.
Total Asset Turnover
Total asset turnover exhibited a high degree of stability with minor fluctuations. The ratio began at 1.33 in March 2022 and experienced a temporary decline to a low of 1.18 in March 2023. Following this dip, a gradual recovery ensued, with the ratio stabilizing between 1.30 and 1.44 through September 2026. The narrow range of movement suggests that the overall asset base has grown in proportion to revenue growth, maintaining a consistent efficiency level.
Equity Turnover
Equity turnover demonstrates a moderate positive trajectory. The ratio remained steady around the 4.1 to 4.2 range throughout 2022 and 2023. An upward movement began in 2024, reaching a peak of 4.71 in December 2025 before settling into a plateau of approximately 4.54 by September 2026. This trend reflects an enhanced efficiency in utilizing shareholders' equity to drive top-line growth.

In summary, the divergence between the stability of the total asset turnover and the significant rise in net fixed asset turnover suggests that the improvements in efficiency are primarily driven by the optimization of fixed assets rather than the overall asset portfolio. The synchronized rise in equity turnover further indicates a strengthening of the return on invested equity relative to sales generation.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Net Fixed Asset Turnover

UnitedHealth Group Inc., net fixed asset turnover calculation (quarterly data)

Microsoft Excel
Sep 30, 2026 Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in millions)
Revenues, customers 111,617 110,809 110,590 112,568 112,029 110,508 108,542 99,256 99,177 97,858 98,785 93,248 91,364 91,788 91,133 81,932 80,381 80,037 79,782
Property, equipment and capitalized software, net 10,950 10,762 10,667 10,762 11,104 10,923 10,734 10,553 10,139 9,801 10,429 11,450 11,070 10,926 10,637 10,128 9,469 9,421 9,183
Long-term Activity Ratio
Net fixed asset turnover1 40.69 41.44 41.78 41.22 38.75 38.22 37.72 37.44 38.37 38.90 35.98 32.10 32.18 31.60 31.35 31.81 33.07 32.33 32.16
Benchmarks
Net Fixed Asset Turnover, Competitors2
Abbott Laboratories 3.74 3.64 3.65 3.75 3.81 3.78 3.87 3.94 3.88 3.98 3.99 3.95 4.18 4.26 4.47 4.76 5.18 5.17 5.00
Elevance Health Inc. 43.15 42.78 42.58 42.23 41.50 40.49 39.35 37.66 38.33 38.30 38.32 39.05 39.41 36.19 36.14 36.07 36.22 36.17 35.81
Intuitive Surgical Inc. 2.04 1.99 1.94 1.88 1.87 1.83 1.82 1.80 1.77 1.84 1.93 2.01 2.23 2.35 2.49 2.62 2.73 2.83 3.00
Medtronic PLC 4.94 4.85 4.88 4.91 5.04 5.13 5.19 5.28 5.54 5.57 5.57 5.61 5.66 5.82 5.88 5.85 6.05 6.13 6.12

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q3 2026 Calculation
Net fixed asset turnover = (Revenues, customersQ3 2026 + Revenues, customersQ2 2026 + Revenues, customersQ1 2026 + Revenues, customersQ4 2025) ÷ Property, equipment and capitalized software, net
= (111,617 + 110,809 + 110,590 + 112,568) ÷ 10,950 = 40.69

2 Click competitor name to see calculations.


The net fixed asset turnover ratio exhibits a distinct upward trajectory over the analyzed period, progressing from 32.16 in March 2022 to 40.69 by September 2026. This trend indicates a systemic improvement in capital efficiency, as the organization generated increasing levels of revenue relative to its investment in property, equipment, and capitalized software.

Initial Stability Phase (March 2022 – December 2023)
During this period, the net fixed asset turnover ratio remained relatively stable, fluctuating within a narrow range between 31.35 and 33.07. While revenues grew from 79,782 million to 93,248 million, this growth was mirrored by a steady increase in net fixed assets, which rose from 9,183 million to 11,450 million. The proportionality between asset expansion and revenue growth resulted in a flat efficiency profile.
Efficiency Transition (March 2024 – December 2024)
A significant shift in asset productivity occurred in the first half of 2024. The turnover ratio climbed sharply to 35.98 in March 2024 and peaked at 38.90 in June 2024. This acceleration was driven by a divergence where revenues continued to rise toward 99,256 million, while the net fixed asset base contracted from its previous peak of 11,450 million down to approximately 10,429 million. This period marks a transition toward a leaner asset structure relative to output.
Optimization and Scaling Phase (March 2025 – September 2026)
The latter part of the period is characterized by sustained high efficiency. The turnover ratio continued to climb, reaching its highest point of 41.78 in March 2026. This was achieved by maintaining a relatively stable asset base—hovering between 10,667 million and 11,104 million—while revenues scaled significantly to reach 111,617 million by September 2026. The resulting ratio of 40.69 at the end of the period suggests a high degree of operating leverage regarding fixed assets.

Overall, the data reveals a strategic shift from a period of proportional asset growth to one of aggressive revenue scaling without a corresponding increase in fixed capital expenditure. The increase in the net fixed asset turnover ratio from approximately 32 to 41 underscores a substantial improvement in the utilization of long-term physical and capitalized software assets to drive top-line growth.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Total Asset Turnover

UnitedHealth Group Inc., total asset turnover calculation (quarterly data)

Microsoft Excel
Sep 30, 2026 Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in millions)
Revenues, customers 111,617 110,809 110,590 112,568 112,029 110,508 108,542 99,256 99,177 97,858 98,785 93,248 91,364 91,788 91,133 81,932 80,381 80,037 79,782
Total assets 312,782 309,727 312,644 309,581 315,269 308,573 309,790 298,278 299,309 286,056 284,210 273,720 282,063 280,164 283,679 245,705 243,064 230,172 221,238
Long-term Activity Ratio
Total asset turnover1 1.42 1.44 1.43 1.43 1.36 1.35 1.31 1.32 1.30 1.33 1.32 1.34 1.26 1.23 1.18 1.31 1.29 1.32 1.33
Benchmarks
Total Asset Turnover, Competitors2
Abbott Laboratories 0.45 0.43 0.41 0.51 0.52 0.51 0.52 0.52 0.55 0.56 0.56 0.55 0.55 0.55 0.56 0.59 0.62 0.61 0.60
Elevance Health Inc. 1.56 1.57 1.58 1.63 1.57 1.54 1.52 1.50 1.48 1.51 1.52 1.56 1.52 1.51 1.46 1.51 1.48 1.47 1.42
Intuitive Surgical Inc. 0.60 0.53 0.53 0.49 0.50 0.45 0.45 0.45 0.44 0.45 0.46 0.46 0.47 0.48 0.49 0.48 0.46 0.44 0.43
Medtronic PLC 0.39 0.38 0.38 0.37 0.37 0.37 0.36 0.36 0.36 0.35 0.35 0.34 0.33 0.33 0.35 0.35 0.35 0.35 0.34

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q3 2026 Calculation
Total asset turnover = (Revenues, customersQ3 2026 + Revenues, customersQ2 2026 + Revenues, customersQ1 2026 + Revenues, customersQ4 2025) ÷ Total assets
= (111,617 + 110,809 + 110,590 + 112,568) ÷ 312,782 = 1.42

2 Click competitor name to see calculations.


The financial trajectory between March 2022 and September 2026 is characterized by a consistent expansion of both top-line revenue and the total asset base, with a distinct period of efficiency volatility occurring in early 2023.

Revenue and Asset Growth Patterns
Revenues demonstrated a sustained upward trend, increasing from 79,782 million USD in March 2022 to 111,617 million USD by September 2026. Parallel to this growth, total assets expanded from 221,238 million USD to 312,782 million USD. A notable acceleration in asset accumulation occurred between December 2022 and March 2023, where assets grew by approximately 37,974 million USD in a single quarter.
Analysis of Total Asset Turnover Volatility
The total asset turnover ratio experienced a significant contraction in March 2023, dropping to a period low of 1.18. This decline indicates that the rapid expansion of the asset base temporarily outpaced revenue growth, leading to a short-term decrease in asset utilization efficiency. This trend reversed quickly, as the ratio recovered to 1.34 by December 2023, suggesting that revenue streams scaled to align with the new asset levels.
Long-term Efficiency Trends
Following a period of stabilization throughout 2024, where the ratio fluctuated narrowly between 1.30 and 1.33, a secondary growth phase in efficiency is observed starting in 2025. The total asset turnover ratio climbed steadily from 1.31 in March 2025 to a peak of 1.44 in June 2026. This progression signifies an optimized capacity to generate higher volumes of revenue per unit of asset invested, ending the period at a higher efficiency level than the initial 2022 baseline.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Equity Turnover

UnitedHealth Group Inc., equity turnover calculation (quarterly data)

Microsoft Excel
Sep 30, 2026 Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in millions)
Revenues, customers 111,617 110,809 110,590 112,568 112,029 110,508 108,542 99,256 99,177 97,858 98,785 93,248 91,364 91,788 91,133 81,932 80,381 80,037 79,782
Shareholders’ equity attributable to UnitedHealth Group 98,096 98,447 97,881 94,110 95,787 94,724 95,038 92,658 94,535 89,359 86,688 88,756 84,494 82,353 81,312 77,772 74,646 72,820 72,766
Long-term Activity Ratio
Equity turnover1 4.54 4.53 4.55 4.71 4.49 4.41 4.26 4.26 4.12 4.27 4.33 4.14 4.22 4.19 4.10 4.14 4.19 4.18 4.06
Benchmarks
Equity Turnover, Competitors2
Abbott Laboratories 0.95 0.91 0.87 0.85 0.86 0.85 0.87 0.88 1.04 1.04 1.04 1.04 1.07 1.08 1.12 1.19 1.26 1.25 1.26
Elevance Health Inc. 4.46 4.43 4.52 4.50 4.40 4.30 4.27 4.24 3.94 4.04 4.20 4.33 4.36 4.31 4.27 4.29 4.22 4.13 3.97
Intuitive Surgical Inc. 0.72 0.61 0.61 0.56 0.57 0.51 0.51 0.51 0.50 0.51 0.52 0.54 0.55 0.56 0.57 0.56 0.53 0.50 0.49
Medtronic PLC 0.72 0.71 0.71 0.70 0.67 0.68 0.68 0.64 0.62 0.62 0.62 0.61 0.60 0.59 0.59 0.60 0.60 0.61 0.61

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q3 2026 Calculation
Equity turnover = (Revenues, customersQ3 2026 + Revenues, customersQ2 2026 + Revenues, customersQ1 2026 + Revenues, customersQ4 2025) ÷ Shareholders’ equity attributable to UnitedHealth Group
= (111,617 + 110,809 + 110,590 + 112,568) ÷ 98,096 = 4.54

2 Click competitor name to see calculations.


The financial trajectory from March 2022 through September 2026 is characterized by consistent growth in both top-line revenues and total shareholders' equity, resulting in a gradual improvement in equity utilization efficiency.

Revenue Growth Patterns
Revenues exhibit a sustained upward trend, increasing from 79,782 million USD in March 2022 to 111,617 million USD by September 2026. Notable accelerations occurred in early 2023 and early 2025, where quarterly revenues jumped significantly, indicating periods of expanded operational scale or pricing adjustments.
Shareholders' Equity Evolution
Equity attributable to the parent company grew from 72,766 million USD to 98,096 million USD over the analyzed period. While the overall trend is positive, the growth was not linear, with periodic fluctuations observed in 2024 and late 2025, suggesting active capital management or shifts in retained earnings.
Equity Turnover Analysis
The equity turnover ratio remained relatively stable between 4.06 and 4.22 throughout 2022 and 2023, reflecting a consistent relationship between the asset base and revenue generation. A shift toward higher efficiency began in 2024, with the ratio climbing to a peak of 4.71 in December 2025. This peak indicates a period of maximum asset productivity relative to equity investment. By 2026, the ratio stabilized at a higher baseline, ranging between 4.53 and 4.54, which represents a permanent improvement in the company's ability to generate revenue from its equity base compared to the 2022-2023 period.

Overall, the data indicates that revenue growth has outpaced the growth of shareholders' equity over the long term. This divergence has led to an increase in the equity turnover ratio, signifying enhanced operational efficiency in utilizing equity to drive sales volume.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?